









Markets
/
Stocks
/
nasdaq-smlr
/

Semler Scientific Inc

SMLR

27.600USD

+0.180+0.66%

Close 11/07, 16:00（ET）Quotes delayed by 15 min

377.80MMarket Cap

10.20P/E TTM



Semler Scientific Inc

27.600

+0.180+0.66%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Semler Scientific Inc

Currency: USD Updated: 2025-11-07

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Semler Scientific Inc's Score

Industry at a Glance

Industry Ranking

88 / 209

Overall Ranking

185 / 4614

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 3 analysts

Buy

Current Rating

75.333

Target Price

+174.74%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Semler Scientific Inc Highlights

StrengthsRisks

Semler Scientific, Inc. develops, manufactures, and markets products and services that assist in evaluating and treating chronic diseases. The Company provides technology solutions to healthcare providers. The Company's flagship product, QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient’s vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger. Infrared light emitted from the clamp on the dorsal surface of the digit is scattered and reflected by the red blood cells coursing through the area of illumination. Returning light is sensed by the sensor. A blood flow waveform is instantaneously constructed by its proprietary software algorithm. Its customers for QuantaFlo include insurance plans, physician groups, risk assessment groups, hospitals and retailers.

Growing

The company is in a growing phase, with the latest annual income totaling USD 56.29M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 56.29M.

Undervalued

The company’s latest PE is 5.53, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 11.18M shares, increasing 2.24% quarter-over-quarter.

Held by HACAX

Star Investor HACAX holds 31.00 shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of 0.24.

Financial Health

Currency: USD Updated: 2025-11-07

The company's current financial score is 7.28, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 8.22M, representing a year-over-year decrease of 43.19%, while its net profit experienced a year-over-year decrease of 608381.82%.

Score

Industry at a Glance

Previous score

7.28

Change



Financials

5.57

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

6.52

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.10

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.23

Key Metrics

Free cash flow

No Data

Semler Scientific Inc's Company Valuation

Currency: USD Updated: 2025-11-07

The company’s current valuation score is 6.18, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 5.53, which is 487.66% below the recent high of 32.52 and 512.97% above the recent low of -22.85.

Score

Industry at a Glance

Previous score

6.18

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 88/209

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-07

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Semler Scientific Inc is 80.00, with a high of 86.00 and a low of 60.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 3 analysts

Buy

Current Rating

75.333

Target Price

+174.74%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

110

Total

Median

Average

Company name

Ratings

Analysts

Semler Scientific Inc

SMLR

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-07

The company’s current price momentum score is 7.48, which is higher than the Healthcare Equipment & Supplies industry's average of 6.88. Sideways: Currently, the stock price is trading between the resistance level at 33.41 and the support level at 21.82, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.47

Change

0.01

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.914

Neutral

RSI(14)

51.954

Neutral

STOCH(KDJ)(9,3,3)

48.791

Buy

ATR(14)

3.016

High Vlolatility

CCI(14)

42.132

Neutral

Williams %R

50.302

Neutral

TRIX(12,20)

-0.291

Sell

StochRSI(14)

76.555

Sell

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

26.624

Buy

MA10

26.884

Buy

MA20

25.529

Buy

MA50

27.805

Sell

MA100

32.567

Sell

MA200

35.822

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-07

The company’s current institutional recognition score is 7.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.42. The latest institutional shareholding proportion is 73.91%, representing a quarter-over-quarter increase of 14.52%. The largest institutional shareholder is The Vanguard, holding a total of 639.47K shares, representing 4.22% of shares outstanding, with 31.79% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Interchange Capital Partners LLC

1.28M

Ridgeback Capital Management, L.P.

936.87K

Chang Family Trust

885.68K

+0.16%

Morgan Stanley Investment Management Inc. (US)

783.35K

+65.58%

Semler (Eric J.D.)

714.02K

+0.94%

The Vanguard Group, Inc.

Star Investors

639.47K

+45.10%

Capital International Investors

696.96K

+12.45%

Citadel Advisors LLC

617.30K

+4048.78%

BlackRock Institutional Trust Company, N.A.

581.96K

+24.67%

Susquehanna International Group, LLP

538.13K

+175.10%

Risk Assessment

Currency: USD Updated: 2025-11-07

The company’s current risk assessment score is 4.22, which is lower than the Healthcare Equipment & Supplies industry's average of 4.58. The company's beta value is 1.33. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.